Travis King, a private 2nd Class U.S. soldier, was identified as the individual that crossed the North and South Korean border earlier this week.
Share:
More In Politics
Abortion Clinic Fire Suspect Set to Take Plea Deal
A plea deal is expected Thursday for a woman charged with setting fire to an abortion clinic in Wyoming.
Multiple Women Testify in Lawsuit Against Texas Abortion Ban
Multiple women testified in a lawsuit against the State of Texas over its abortion ban.
President Biden Visits Pennsylvania Shipyard
President Biden Visits Pennsylvania Shipyard
House Votes on Bill to Overhaul Commercial Air Travel
The House is set to vote Thursday on its version of a bill to overhaul and improve commercial air travel through funding for the FAA.
IRS Agents Allege Political Bias in Hunter Biden Case
At a House hearing on Wednesday, two IRS whistleblowers accused the Justice Department of giving Hunter Biden special treatment in his tax evasion case due to political concerns.
Women Testify in Suit Against Texas Abortion Ban
Multiple women suing the State of Texas over its abortion law took the stand on Wednesday and gave emotional testimony about their experiences.
Border Patrol Fails to Assess Medical Needs for Children With Preexisting Conditions, Report Says
Border Patrol does not have protocols for assessing medical needs of children with preexisting conditions, according to an independent report made public Tuesday on the death of an 8-year-old girl from Panama who was in federal custody.
Another Bus of Migrants Arrive in Los Angeles
For the fourth time in a matter of weeks, a bus carrying migrants from Texas arrived in Los Angeles late Tuesday night.
DEA’s No. 2 Quits Amid Reports of Previous Consulting Work for Big Pharma
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he once consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma.
